AnalystsGavin Clark-GartnerGavin Clark-Gartner's Stock Forecasts
AnalystsGavin Clark-Gartner
Sectors:
Analyst Ranking
Bottom 7%
#4572 out of 4870 analysts
Average Return
-13.23%
Win Rate
36%9 out of 25
Risk vs Reward
Poor
Good
Gavin Clark-Gartner's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Argenx SeARGX | +76.16% | $354.13 | $623.82 | 2023-12-20 - 2024-12-20 | Buy |
C4 Therapeutics IncCCCC | +48.96% | $3.35 | $4.99 | 2023-05-29 - 2024-05-29 | Buy |
Mirum Pharmaceuticals IncMIRM | +37.60% | $28.91 | $39.78 | 2023-10-16 - 2024-10-16 | Buy |
Argenx SeARGX | +37.19% | $466.42 | $639.90 | 2024-07-11 - 2025-05-01 | Buy |
Abbvie IncABBV | +17.55% | $148.70 | $174.79 | 2023-02-08 - 2024-02-08 | Buy |
Gavin Clark-Gartner Analyst Color
Get additional color on Gavin Clark-Gartner's coverage of popular stocks
Gavin Clark-Gartner's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Proqr Therapeutics NvPRQR | 1 | Buy | $5.00 | +190.70% | Initiates Coverage On | 3 days ago |
Abbvie IncABBV | 3 | Buy | $205.00 | +6.03% | Maintains | 4 days ago |
Mind Medicine IncMNMD | 1 | Buy | $23.00 | +249.01% | Initiates Coverage On | 3 months ago |
Cabaletta Bio IncCABA | 2 | Hold | $6.00 | +380.00% | Downgrades | 4 months ago |
Argenx SeARGX | 4 | Buy | $706.00 | +10.33% | Maintains | 5 months ago |
Sarepta Therapeutics IncSRPT | 9 | Buy | $170.00 | +170.79% | Maintains | 6 months ago |
Jasper Therapeutics IncJSPR | 2 | Buy | $65.00 | +1,108.18% | Maintains | 8 months ago |
Foghorn Therapeutics IncFHTX | 1 | Buy | $20.00 | +380.77% | Initiates Coverage On | 8 months ago |
Krystal Biotech IncKRYS | 1 | Buy | $206.00 | +24.33% | Maintains | 9 months ago |
Mirum Pharmaceuticals IncMIRM | 2 | Buy | $66.00 | +52.00% | Maintains | 9 months ago |
Aclaris Therapeutics IncACRS | 1 | Buy | $22.00 | N/A | Initiates Coverage On | 2 years ago |
C4 Therapeutics IncCCCC | 1 | Buy | $10.00 | N/A | Maintains | 2 years ago |
Inhibrx IncINBX1 | 1 | Buy | $60.00 | N/A | Maintains | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.